|
FDA’s Hamburg Testifies on Patient Protection, User Fees
FDA Commissioner Margaret Hamburg yesterday told a Senate appropriations subcommittee that an increase of $101 million in funding — $51 million
of which would come from two new user fees — would be needed to finance a critical patient-safety measure.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives